nal disease (9% vs 4%; p=0.0003). Proportion of health care-associated IE was higher in the bioprosthesis group (26% vs 17%; p<.0001). Intracardiac abscesses were more frequent in the bioprosthesis group (30% vs 23%; p=0.0044). Both inhospital and 1-year death rates were higher in the bioprosthesis group, 20.5% vs 14.0% (p=0.0009) and 25.3% vs 16.6% (p<.0001), respectively. Only 3 variables were independently associated with the type of prosthesis implanted. Mechanical prostheses were less commonly implanted in older patients (odds ratio: 0.64 for every 10 years; 0.56 -0.73), and in patients with a history of cancer (0.72; 0.53 -0.98), but were more commonly implanted in mitral position (1.60; 1.29 -2.00). In the multivariable analysis, bioprosthesis was independently associated with 1-year mortality (hazard ratio: 1.298; 1.011-1.665; p=0.041). In sub-group analysis, biologic valve replacement remained independently associated with 1 year mortality in patients less than 65 years old, but not in older patients. Conclusion: Patients with IE who receive a biologic valve replacement have significant differences in clinical characteristics compared to patients who receive a mechanical prosthesis. Biologic valve replacement is independently associated with a higher in-hospital and 1-year mortality, a result which is likely related to patient characteristics rather than valve dysfunction. Purpose: The Intracranial Haemorrhages (ICH) represent up to 30% of neurological complications of endocarditis. They are due to three mechanisms: the haemorrhagic conversion after cerebral embolism, the rupture of an intracerebral infectious aneurysm (ICIA) and the septic erosion of the arterial wall without infectious aneurysm. These complications lead to an excess mortality and complicate the achievement of valvular surgery. We aimed (1) to determine predictors of ICH, (2) and to describe their management and prognosis in a reference centre. Methods: In a retrospective single centre study, conducted from 2001 to 2012, all consecutive patients with definite infective endocarditis were included. Clinical, biological, microbiological, echocardiographic and complications evaluations were performed on all patients. ICH were assessed by using cerebral computed tomography and/or magnetic resonance imaging, and cerebral angiography. Predictors of ICH were determined by logistic regression analysis. Results: Among the 533 patients included, 34 (6.4%) experienced ICH. We found 12 (2.3%) intracranial haemorrhagic conversions, 11 (2.1%) rupture of ICIA, and 11 (2.1%) septic erosion of the arterial wall without ICIA. Multivariable analysis identified male gender (OR,2.9; 95% CI, 1.02-8.2; p=0.04), thrombocytopenia (OR, 3.2; 95% CI, 1.5-7.0; p<0.005) and the presence of a previous cerebral embolism (OR, 4.9; 95% CI, 2.3-10.5; p<0.005) as the main predictors of ICH. Among the patients with ICH, 5 (15%) died because of this complication, 19 (56%) were treated medically, 7 (21%) had a neurosurgical procedure and 3 (9%) had an interventional endovascular treatment. Of the 27 (79%) patients with an indication of valvular surgery, 3 (11%) died, 6 (22%) were contraindicated because of their neurological status, 2 (7%) were contraindicated for another cause and 16 (59%) were operated (8 during the antibiotic period [median time = 23 days after the ICH]; and 8 after the antibiotic period, [median time= 85 days after ICH]). No postoperative neurological deterioration was observed. Conclusion: The predictors of ICH in infective endocarditis are: thrombocytopenia and the presence of a cerebral embolism. If a surgical indication persists, the presence of an ICH is not always a formal contraindication and must be managed by a multidisciplinary approach. Purpose: Worldwide Staphylococcus aureus (S. aureus) is the second most common microorganism isolated from blood cultures and S. aureus bacteraemia is a major cause of serious cardiac infections such as infectious endocarditis and cardiac device infections. Specific non-genetic susceptibility risk factors for S. aureus bacteraemia have been demonstrated in smaller studies. Prior to their first hospitalization with S. aureus bacteraemia we compared the general risk profile of a very large cohort of S. aureus bacteraemia patients with the risk profile of the total Danish population. Methods: To identify people, hospitalized with a first episode of S. aureus bacteraemia from the 1st of January 1996 -the 1st of January 2012, we used the Danish S. aureus bacteraemia registry. To obtain information on date of birth, sex, age, cause of death, medical status and co-morbidities we made a linkage between every patient's personal identification number and 7 nationwide registers. Poisson regression was used to determine standardized incidence ratios (SIRs) of several co-morbidities with the Danish population as a reference. Results: We identified 20.682 subjects (61,3% males) diagnosed with primary S. aureus bacteraemia, with a median age of ). In our studypopulation, we observed a significant increase of ischemic heart disease (SIR of 2.01, 95% confidence interval (CI):1.98-2.04, p<0.0001), heart failure (SIR of 2.88CI:2.83-2.94, p<0.0001), cardiac arrhythmias (SIR of 2.88, CI:2.83-2.94, p<0.0001) and periphery vascular disease (SIR of 2.81,CI:2.74-2.88, p<0.0001) as compared to the general Danish population. Additionally, we found an increased prevalence of diabetes (SIR of 4.44, p<0.0001), kidney diseases (SIR of 8.87, p<0.0001) and cancer with metastasis (SIR of 1.97, CI:1.89-2.05, p<0.0001) in our study-population prior to the verification of S. aureus bacteraemia. Finally, HIV (SIR of 8.31, p<0.0001) and rheumatic disorders (SIR of 1.91, CI:1.87-1.96, p<0.0001) were also significantly more frequent in the S. aureus bacteraemia cohort, as compared to the general population. However, 3453 patients did not suffer from any co-morbidities prior to the infection. Moreover, we found that 6801 subjects in the study-population had been operated 3 month prior to the S. aureus bacteraemia diagnose, while 1009 of the patients never had an invasive procedure requiring hospitalization. Conclusion: Multiple comorbidity including a range of cardiac diseases increased the risk of Staphylococcus aureus bacteraemia in the Danish Population.
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Purpose: Worldwide Staphylococcus aureus (S. aureus) is the second most common microorganism isolated from blood cultures and S. aureus bacteraemia is a major cause of serious cardiac infections such as infectious endocarditis and cardiac device infections. Specific non-genetic susceptibility risk factors for S. aureus bacteraemia have been demonstrated in smaller studies. Prior to their first hospitalization with S. aureus bacteraemia we compared the general risk profile of a very large cohort of S. aureus bacteraemia patients with the risk profile of the total Danish population. Methods: To identify people, hospitalized with a first episode of S. aureus bacteraemia from the 1st of January 1996 -the 1st of January 2012, we used the Danish S. aureus bacteraemia registry. To obtain information on date of birth, sex, age, cause of death, medical status and co-morbidities we made a linkage between every patient's personal identification number and 7 nationwide registers. Poisson regression was used to determine standardized incidence ratios (SIRs) of several co-morbidities with the Danish population as a reference. Results: We identified 20.682 subjects (61,3% males) diagnosed with primary S. aureus bacteraemia, with a median age of 66.37 (IQR=50.97-77.51). In our studypopulation, we observed a significant increase of ischemic heart disease (SIR of 2.01, 95% confidence interval (CI):1.98-2.04, p<0.0001), heart failure (SIR of 2.88CI:2.83-2.94, p<0.0001), cardiac arrhythmias (SIR of 2.88, CI:2.83-2.94, p<0.0001) and periphery vascular disease (SIR of 2.81,CI:2.74-2.88, p<0.0001) as compared to the general Danish population. Additionally, we found an increased prevalence of diabetes (SIR of 4.44, p<0.0001) , kidney diseases (SIR of 8.87, p<0.0001) and cancer with metastasis (SIR of 1.97, CI:1.89-2.05, p<0.0001) in our study-population prior to the verification of S. aureus bacteraemia. Finally, HIV (SIR of 8.31, p<0 .0001) and rheumatic disorders (SIR of 1.91, CI:1.87-1.96, p<0.0001) were also significantly more frequent in the S. aureus bacteraemia cohort, as compared to the general population. However, 3453 patients did not suffer from any co-morbidities prior to the infection. Moreover, we found that 6801 subjects in the study-population had been operated 3 month prior to the S. aureus bacteraemia diagnose, while 1009 of the patients never had an invasive procedure requiring hospitalization. Conclusion: Multiple comorbidity including a range of cardiac diseases increased the risk of Staphylococcus aureus bacteraemia in the Danish Population.
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Diabetes is a risk factor for septic shock in left-sided infective endocarditis 
